Generali Investments CEE investicni spolecnost a.s. bought a new position in shares of Healthcare Realty Trust Incorporated (NYSE:HR – Free Report) in the 4th quarter, HoldingsChannel.com reports. The fund bought 81,900 shares of the real estate investment trust’s stock, valued at approximately $1,388,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Bank of New York Mellon Corp boosted its position in shares of Healthcare Realty Trust by 12.0% during the 4th quarter. Bank of New York Mellon Corp now owns 4,630,973 shares of the real estate investment trust’s stock worth $78,495,000 after purchasing an additional 495,599 shares during the period. Pzena Investment Management LLC purchased a new position in shares of Healthcare Realty Trust during the third quarter worth $40,392,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Healthcare Realty Trust by 358.2% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,142,110 shares of the real estate investment trust’s stock worth $38,879,000 after buying an additional 1,674,583 shares during the period. Candriam S.C.A. grew its stake in shares of Healthcare Realty Trust by 201.4% in the fourth quarter. Candriam S.C.A. now owns 1,729,651 shares of the real estate investment trust’s stock valued at $29,318,000 after buying an additional 1,155,745 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Healthcare Realty Trust by 289.5% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,552,109 shares of the real estate investment trust’s stock valued at $26,308,000 after buying an additional 1,153,657 shares during the period.
Insider Transactions at Healthcare Realty Trust
In other news, Director Peter F. Sr Lyle, Sr. acquired 10,000 shares of the stock in a transaction that occurred on Friday, December 13th. The shares were purchased at an average cost of $17.21 per share, for a total transaction of $172,100.00. Following the transaction, the director now directly owns 26,576 shares in the company, valued at approximately $457,372.96. This represents a 60.33 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.56% of the company’s stock.
Healthcare Realty Trust Stock Up 1.6 %
Healthcare Realty Trust (NYSE:HR – Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.01. The business had revenue of $309.77 million during the quarter, compared to analysts’ expectations of $303.81 million. Healthcare Realty Trust had a negative net margin of 51.60% and a negative return on equity of 11.20%. The company’s revenue for the quarter was down 6.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.39 EPS. As a group, research analysts anticipate that Healthcare Realty Trust Incorporated will post 1.59 earnings per share for the current fiscal year.
Healthcare Realty Trust Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 19th. Stockholders of record on Monday, March 3rd will be issued a $0.31 dividend. The ex-dividend date is Monday, March 3rd. This represents a $1.24 dividend on an annualized basis and a dividend yield of 7.39%. Healthcare Realty Trust’s payout ratio is currently -69.66%.
Analyst Ratings Changes
HR has been the subject of a number of research analyst reports. JPMorgan Chase & Co. cut Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 target price for the company. in a report on Friday, December 20th. Wedbush restated an “outperform” rating and issued a $16.00 price objective on shares of Healthcare Realty Trust in a report on Thursday, February 20th. Jefferies Financial Group downgraded shares of Healthcare Realty Trust from a “buy” rating to a “hold” rating and cut their target price for the stock from $19.00 to $17.00 in a research note on Thursday, January 2nd. StockNews.com cut shares of Healthcare Realty Trust from a “hold” rating to a “sell” rating in a research report on Wednesday. Finally, Scotiabank cut their price objective on Healthcare Realty Trust from $18.00 to $17.00 and set a “sector perform” rating on the stock in a research report on Tuesday, February 25th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $17.20.
Get Our Latest Stock Report on Healthcare Realty Trust
About Healthcare Realty Trust
Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.
Recommended Stories
- Five stocks we like better than Healthcare Realty Trust
- Investing in Commodities: What Are They? How to Invest in Them
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- Pros And Cons Of Monthly Dividend Stocks
- 3 Stocks to Buy While Others Stay on the Sidelines
- How to Invest in Insurance Companies: A Guide
- MarketBeat Week in Review – 03/03 – 03/07
Want to see what other hedge funds are holding HR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthcare Realty Trust Incorporated (NYSE:HR – Free Report).
Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.